Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2021-08-06	TSTBio’s iProtin system receives CE mark	IBMI
2021-08-06	NaviFUS Receives Approval of Focused Ultrasound Trial to Enhance Radiotherapy	Press Release
2021-08-04	Lumosa Therapeutics Announces Positive Result from LT3001 Phase 2A Clinical Trial in Acute Ischemic Stroke	Press Release
2021-08-04	Precision Medicine and Genomics Center opens, targeting cancer and inherited disease	IBMI
2021-08-04	Lotus confirms ANDA filing and patent challenge for generic RYDAPT®	Press Release
2021-08-03	QPS Supports COVID-19 Vaccine Development In Taiwan	Press Release
2021-08-03	Tanvex submits BLA for TX05 (Herceptin Biosimilar) to FDA	IBMI
2021-08-02	Taiwan’s biotechnology and pharmaceutical sectors join hands in the post-COVID economy	IBMI
2021-07-30	Formosa Plastics commits $390m to medical supplies	IBMI
2021-07-28	Taiwan brings hope for breast cancer patients with new epigenetic drug	BioSpectrum

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978